Medacta Group (Switzerland) Today
| MOVE Stock | 110.60 0.20 0.18% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Medacta Group is selling for under 110.60 as of the 15th of December 2024; that is 0.18% down since the beginning of the trading day. The stock's lowest day price was 110.2. Medacta Group has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 15th of November 2024 and ending today, the 15th of December 2024. Click here to learn more.
Moving together with Medacta Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Medacta Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Medacta Group's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Medacta Group or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Medacta Group SA (MOVE) is traded on SIX Swiss Exchange in Switzerland and employs 1,421 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medacta Group's market, we take the total number of its shares issued and multiply it by Medacta Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medacta Group SA operates under Healthcare sector and is part of Medical Devices industry. The entity has 19.98 M outstanding shares.
Medacta Group generates positive cash flow from operations, but has no cash available
Check Medacta Group Probability Of Bankruptcy
Ownership AllocationMedacta Group SA maintains a total of 19.98 Million outstanding shares. Medacta Group SA secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 69.53 % of Medacta Group SA outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Medacta Ownership Details
Medacta Group SA Risk Profiles
Although Medacta Group's alpha and beta are two of the key measurements used to evaluate Medacta Group's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.3 | |||
| Standard Deviation | 1.68 | |||
| Variance | 2.82 | |||
| Risk Adjusted Performance | (0.07) |
Medacta Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medacta Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Medacta Group Corporate Management
Elected by the shareholders, the Medacta Group's board of directors comprises two types of representatives: Medacta Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medacta. The board's role is to monitor Medacta Group's management team and ensure that shareholders' interests are well served. Medacta Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medacta Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alessandro Siccardi | Supply Director | Profile | |
| Donato Cortesi | S Board | Profile | |
| Gianluca Olgiati | Director Marketing | Profile | |
| Alberto Siccardi | Founder Chairman | Profile | |
| Francesco Siccardi | Chief Officer | Profile | |
| Asif Hussain | HR Director | Profile | |
| Corrado Farsetta | Chief Officer | Profile |
Additional Tools for Medacta Stock Analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.